Dexco Holds Extraordinary Shareholder Meeting

• Dexco shareholders approved Duratex Florestal’s partial spin-off and absorption of spun-off assets at an extraordinary meeting on October 26, 2026.
• Ernst & Young’s appointment ratified; valuation report approved, valuing spun-off assets at R$ 38.1 million as of July 31, 2026.
• Administrators authorized to implement the transaction without changing share capital or bylaws; approval does not establish completion.
• Shareholders approved bylaw amendments reflecting current share capital and issued shares, including an increase in the authorized capital limit.
• Article 19 amendment approved to rename the IT and Digital Innovation Committee the Transformation Committee; consolidated bylaws also adopted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexco SA published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.